Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Aug 30, 2024

SELL
$0.78 - $1.09 $585 - $817
-750 Closed
0 $0
Q4 2018

Aug 30, 2024

BUY
$0.63 - $1.0 $472 - $750
750 New
750 $531,000
Q2 2018

Aug 30, 2024

SELL
$0.91 - $1.45 $3,640 - $5,800
-4,000 Reduced 84.21%
750 $728,000
Q2 2017

Aug 30, 2024

BUY
N/A
4,750
4,750 $2.04 Million

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About PALATIN TECHNOLOGIES INC


  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $9.76M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.